Skip to main content
Clinical Trials/IRCT2017083027520N9
IRCT2017083027520N9
Recruiting
Phase 1

A Clinical trial to assess the effect of Natural Killer Cell transplantation in treatment of patients with Acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL)

Stem Cell And Regenerative Medicine Institute0 sites10 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Stem Cell And Regenerative Medicine Institute
Enrollment
10
Status
Recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Stem Cell And Regenerative Medicine Institute

Eligibility Criteria

Inclusion Criteria

  • 1\-Age range of 18\- 25 years for ALL patients; 2\-Age range over 50 years for patients with CLL; 3\- Those who have a proper cell donors with incongruent KIR (Haploidentical KIR\-L mismatched donor); 4\- Patients with adequate organ function; 5\-Access to the patient for the continuation of treatment and follow\-up (preferably from Azeri\-speaking patients for easier access and removal of the Zentique variable);
  • Exclusion criteria : 1\-Patients with active and uncontrolled infections; 2\-Abnormal kidney, lung and liver function, measured by serum creatinine (serum creatinine\> 2 mg / dl), saturated oxygen O2 \= 96%) (Sat and liver enzymes (ALT / AST\> 2\.5 x N); 3\-Patients with Down syndrome; 4\- Patients with acute promyelocytic leukemia

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials